ARTG Entry

SUSVIMO

ARTG entry for SUSVIMO (Ranibizumab), ARTG 510105 — Product Information, dosage form, registration history. Compiled by arcimedes.

• Sponsor: Roche Products
• Active ingredient: Ranibizumab
• Therapeutic area: Ophthalmology

TGA Public Summary — ARTG 510105